Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis.
Journal article published in 2014 by
Stanislas Faguer,
Michael Peres,
Inès Ferrandiz,
Audrey Casemayou,
Julie Belliere,
Olivier Cointault,
François Vergez 
,
Laurence Lavayssiere,
Marie-Béatrice Nogier,
Grégoire Prevot,
Antoine Huart,
Christian Recher,
Lionel Rostaing
,
Laurence Lavayssiere,
Marie-Béatrice Nogier,
Grégoire Prevot,
Antoine Huart,
Christian Recher,
Lionel Rostaing
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 